An Australian-led international clinical trial will scientifically investigate the efficacy of the approach within a large cohort of eligible glioblastoma patients and could commence within a year. The study will trial the use of double immunotherapy. In some patients, double immunotherapy will be combined with chemotherapy. The trial will be led by The Brain Cancer Centre, which has world-leading expertise in glioblastoma. “I am delighted to be handing the baton to Dr Jim Whittle, a leading Aus...